Our study proposed RORα as a novel target against high glucose-induced cardiac fibroblasts proliferation, which is beneficial to clarify ideal therapeutic implication for diabetic cardiomyopathy. The gene discussed is RORA; the disease is diabetic cardiomyopathy.